Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Aurora Kinase
    (1)
  • E3 Ligase Ligand-Linker Conjugate
    (1)
  • Ligand for E3 Ligase
    (1)
  • PROTACs
    (1)
  • Others
    (4)
Filter
Search Result
Results for "

thalidomide-peg2-c2-nh2

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    8
    TargetMol | Inhibitors_Agonists
  • PROTAC Products
    8
    TargetMol | PROTAC
Thalidomide-PEG2-C2-NH2
Thalidomide-NH-PEG2-C2-NH2
T188132093416-32-9
Thalidomide-O-amido-PEG3-C2-NH2 is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and 2-unit PEG linker used in PROTAC technology[1].
  • Inquiry Price
Size
QTY
Thalidomide-PEG2-C2-NH2 hydrochloride
Thalidomide-NH-PEG2-C2-NH2 hydrochloride
T188112245697-87-2
Thalidomide-O-amido-PEG3-C2-NH2 hydrochloride, a synthesized E3 ligase ligand-linker conjugate, combines a Thalidomide-based cereblon ligand with a two-unit PEG linker for use in PROTAC technology[1].
  • Inquiry Price
Size
QTY
Thalidomide-PEG2-C2-NH2 TFA
Thalidomide-NH-PEG2-C2-NH2 TFA
T188122097509-36-7
Thalidomide-O-amido-PEG3-C2-NH2 TFA, a synthesized E3 ligase ligand-linker conjugate, combines the cereblon ligand based on Thalidomide and a 2-unit PEG linker for use in PROTAC technology[1].
  • Inquiry Price
Size
QTY
Thalidomide-O-amido-PEG2-C2-NH2 TFA
E3 Ligase Ligand-Linker Conjugates 24 TFA, Cereblon Ligand-Linker Conjugates 10 TFA
T179181957235-75-4
Thalidomide-O-amido-PEG2-C2-NH2 TFA (E3 Ligase Ligand-Linker Conjugates 24 TFA) is a synthesized E3 ligase ligand-linker conjugate incorporating the Thalidomide-based cereblon ligand and a 2-unit PEG linker, utilized in PROTAC technology.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
Thalidomide-O-amido-PEG2-C2-NH2 hydrochloride
T188192376990-30-4
Thalidomide-O-amido-PEG2-C2-NH2 hydrochloride, incorporating an E3 ligase ligand and a linker, can be used as an immunomodulator for the treatment of cancer.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
Thalidomide-O-amido-PEG2-C2-NH2
Cereblon Ligand-Linker Conjugates 10,E3LigaseLigand-LinkerConjugates24,Thalidomide-O-amido-PEG2-C2-NH2
T393751957235-74-3
Thalidomide-O-amido-PEG2-C2-NH2, which combines an E3 ligase ligand with a linker, serves as an immunomodulator for cancer treatment.
  • Inquiry Price
Size
QTY
JB300
T2042233038446-90-8
JB300 is a PROTAC-based compound that serves as a highly selective degrader of Aurora A, with a DC50 of 30 nM. It is utilized in cancer research. JB300 comprises the PROTAC target protein ligand MK-5108 [pink part], E3 ligase ligand Thalidomide-O-COOH [blue part], and PROTAC Linker Boc-NH-PEG2-C2-NH2 [black part]. The conjugate of the E3 ubiquitin ligase ligand and linker is Thalidomide-O-COOH-NH2-C2-PEG2-NH-Boc.
  • Inquiry Price
Size
QTY
Thalidomide-O-CH2-CO-NH-C2-PEG2-NH-Boc
T2042831957235-73-2
Thalidomide-O-COOH-NH2-C2-PEG2-NH-Boc is a conjugate combining an E3 ligase ligand with a linker, featuring a Thalidomide-based CEREBLON ligand and a PEG linker. It serves as a component in the synthesis of the PROTAC degrader JB300.
  • Inquiry Price
Size
QTY